Intercorp Financial Services (IFS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Feb, 2026Executive summary
Achieved record net income of S/ 1,943 million in 2025, up 49% year-over-year, with ROE at 16.8% and strong performance across all business segments, especially insurance and wealth management.
Digital initiatives and engagement, including Plin and Izipay, drove customer growth, with 84% of retail clients now digital and retail primary banking customers up 11% YoY.
Financial highlights
Revenues grew 13% YoY to S/ 8,151 million; net interest and similar income at S/ 4,629 million; NIM at 5.1%.
Net income reached S/ 1,943 million, a 49% increase from the prior year; ROE at 16.8%.
Cost-to-income ratio improved to 36.8%; cost of risk at 2.3% for FY25.
Loan-to-deposit ratio at 92%; deposits accounted for over 81% of total funding.
Equity attributable to shareholders up 13.1% YoY to S/ 12,422 million.
Outlook and guidance
High single-digit loan growth expected, with focus on digital transformation, efficiency, and customer-centricity.
2026 ROE expected around 17%, with a midterm target of 18%.
NIM and risk-adjusted NIM expected to improve further in 2026 as higher-yielding loans gain relevance.
Cost-to-income ratio to be maintained around 37%.
Latest events from Intercorp Financial Services
- Net profit doubled QoQ in 2Q24, led by banking, insurance, and digital growth; ROE reached 11.2%.IFS
Q2 20242 Feb 2026 - Q3 net profit doubled YoY to S/ 390 million, with ROE at 15.1% and strong segment growth.IFS
Q3 202414 Jan 2026 - Q4 net income rose 71% YoY, ROE topped 18%, and 2025 guidance targets 16% ROE and loan growth.IFS
Q4 202417 Dec 2025 - Q2 2025 net income doubled YoY to S/ 580m, ROE 20.7%, with strong digital and investment gains.IFS
Q2 202523 Nov 2025 - Net income up 216% YoY in Q1 2025, with ROE at 16.3% and strong digital and commercial growth.IFS
Q1 202519 Nov 2025 - Net profit up 81% YoY, strong ROE and digital growth, Rutas de Lima impairment impacted Q3.IFS
Q3 20258 Nov 2025